Platelet-rich plasma ameliorates lipopolysaccharide-induced cardiac injury by inflammation and ferroptosis regulation.

Jiao Y, Zhang Q, Zhang J, Zha Y, Wang J, Li Y, Zhang S

Open source

DOI
10.3389/fphar.2022.1026641
Published
2022
Container
Frontiers in pharmacology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2022.1026641,
  title = {Platelet-rich plasma ameliorates lipopolysaccharide-induced cardiac injury by inflammation and ferroptosis regulation.},
  author = {Jiao Y and Zhang Q and Zhang J and Zha Y and Wang J and Li Y and Zhang S},
  year = {2022},
  journal = {Frontiers in pharmacology},
  doi = {10.3389/fphar.2022.1026641},
  url = {https://doi.org/10.3389/fphar.2022.1026641}
}

RIS

TY  - JOUR
TI  - Platelet-rich plasma ameliorates lipopolysaccharide-induced cardiac injury by inflammation and ferroptosis regulation.
AU  - Jiao Y
AU  - Zhang Q
AU  - Zhang J
AU  - Zha Y
AU  - Wang J
AU  - Li Y
AU  - Zhang S
PY  - 2022
JO  - Frontiers in pharmacology
DO  - 10.3389/fphar.2022.1026641
UR  - https://doi.org/10.3389/fphar.2022.1026641
ER  - 

APA

Y, J., Q, Z., J, Z., Y, Z., J, W., Y, L., & S, Z. (2022). Platelet-rich plasma ameliorates lipopolysaccharide-induced cardiac injury by inflammation and ferroptosis regulation.. Frontiers in pharmacology. https://doi.org/10.3389/fphar.2022.1026641

Source records